NCT03906201

Effect of Phytoecdysterone Administration in Subjects With Prediabetes

Status unknown NA Last updated 31 October 2019

What this trial tests

NA trial testing Ecdysterone in PreDiabetes in 34 participants. Status unknown.

Timeline

6 February 2019

Primary endpoint
31 July 2020

31 July 2020

Quick facts

Lead sponsor	University of Guadalajara
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	34
Start date	6 February 2019
Primary completion	31 July 2020
Estimated completion	31 July 2020
Sites	1 location across Mexico

Drugs / interventions tested

• Ecdysterone
• Placebo

Conditions studied

• PreDiabetes — all drugs for PreDiabetes →

Sponsor

University of Guadalajara

Who can join

Adults 30 to 60, any sex, with PreDiabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prediabetes is the term used for people whose glucose levels do not meet the criteria for diabetes but are too high to be considered normal. This is defined by the presence of blood glucose between 100-125 mg / dL, values per glucose tolerance curve of 140-199mg / dL and/or HbA1c 5.7-6.4%. Prediabetes should not be considered as a clinical entity in itself, but as a risk factor for diabetes and cardiovascular disease (CVD). Prediabetes is associated with obesity (especially abdominal or visceral obesity), dyslipidemia with elevated triglycerides and/or low HDL cholesterol, and hypertension.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.